StockWatch
·
Pharmaceuticals
Quarterly Result13 Nov 2026, 06:55 pm

Auro Laboratories declares Unaudited Q2 FY27 Results

AI Summary

Auro Laboratories Limited announced its unaudited financial results for the quarter and half-year ended September 30, 2026. The Board of Directors approved these results during their meeting held on November 13, 2026. The company also submitted the Limited Review Report from its Statutory Auditors. The results will be published in newspapers as per SEBI regulations.

Key Highlights

  • Unaudited financial results for Q2 FY27 declared.
  • Board of Directors approved the results on November 13, 2026.
  • Limited Review Report from Statutory Auditors enclosed.
  • Results to be published in newspapers.
  • Standalone financial results for the quarter and half-year ended September 30, 2026.